By | October 25, 2014




The project will involve: The selection of a limited number of advanced bioceramic materials (apatite containing bioceramics, calcium phosphate and calcium sulphate based materials, mesoporous bioactive glasses and borosilicate glasses) that have potential to create high added value biomedical products for the SME partners. The development of advanced high added value medical devices that offer improved and controlled biological interaction, and become part of the biological system. Research to modify and adapt the advanced bioceramic materials for new production processes, suitable for future in-hospital or in-clinic manufacture of personalised devices. Full assessment of the new bioceramic materials and devices, on the grounds of potential clinical effectiveness, economics, and environmental impact.


Leitat’s role in the project: LEITAT will lead WPs 10 and 12, and contribute to WPs 7, 8 and 9. LEITAT will perform life-cycle costing and environmental analysis within WP10, and will manage the dissemination and exploitation activities through WP12. LEITAT will contribute design and analysis expertise to WP’s 7, 8, and 9.


Number of Contract: FP7/280575


Coordinator: University of Newcastle


Email LEITAT manager in charge: Izabel Alfany




Start: 01/04/2012


Duration: 48 months




University   of Newcastle upon Tyne UK
Sagetis   Biotech SL Spain
BionicaTech   s.r.l Italy
Orla Protein technologies Ltd UK
Karolinska   Institutet Sweden
LEITAT   Technological Center Spain
Universidade de Evora Portugal
Glass Technology Services Limited UK
Institut Químic de Sarrià Spain
Fondazione del Piemonte per   l’Oncologia Italy
Joint Replacement Instrumentation   Limited UK

Leave a Reply

Your email address will not be published.